SINOPHARM (01099) intends to appoint Sun Jinglin as an executive director.
China National Pharmaceutical Group Corporation (01099) announced in a statement that on January 8, 2025, the board of directors has resolved to recommend the appointment of Mr. Sun Jinglin...
Sinopharm (01099) announced that on January 8, 2025, the board of directors proposed to appoint Mr. Sun Jinglin (Mr. Sun) as an executive director, and to appoint Mr. Hu Ligang (Mr. Hu), Mr. Zu Jing (Mr. Zu), and Mr. Xing Yonggang (Mr. Xing) as non-executive directors.
Due to work requirements, Mr. Wang Kan and Mr. Wang Peng resigned as non-executive directors on January 8, 2025, and their resignations took effect immediately.
Related Articles
Shenzhen Hello Tech Energy(301327.SZ): Strong performance hits record high, revenue and net profit both break through.
Johnson & Johnson's financial condition is stable, and Standard and Poor's has removed the downgrade warning.
HK Bull/Bear Outstanding Qty Ratio(52:48) | April 26th
Shenzhen Hello Tech Energy(301327.SZ): Strong performance hits record high, revenue and net profit both break through.
Johnson & Johnson's financial condition is stable, and Standard and Poor's has removed the downgrade warning.
HK Bull/Bear Outstanding Qty Ratio(52:48) | April 26th
RECOMMEND
Pan Gongsheng: Will implement a moderately loose monetary policy to promote high-quality development of the Chinese economy.
25/04/2025
Canadian Prime Minister Trudeau: No rush to reach agreement with Trump, US side eventually needs to face reality.
25/04/2025
Alphabet (GOOG.US, GOOGL.US) first quarter revenue and profits exceed expectations, driven by AI and cloud computing performance growth.
25/04/2025
